KreLo GmbH Medical Diagnostics

KreLo GmbH Medical Diagnostic was founded in 2004 at the Biotechnology Center in Ulm (TFU) and began as a Start up by spin off from University of Ulm.

The work therein was focused on research and development of IVD-Assay in autoimmunity.

KreLo GmbH Medical Diagnostics developed the first test for the direct detection of Graves‘ disease inducing autoantibodies with a new technology, called bridge assay, on microtiter plates (sTRAb). This method was transferred to Immulit TSI of Siemens Healthcare. Further new technologies are based on paramagnetic beads technology.